NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 88 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 110.31 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $9,000 | -81.6% | 24,984 | -79.2% | 0.00% | – |
| Q3 2017 | $49,000 | +2.1% | 119,910 | +27.6% | 0.00% | – |
| Q2 2017 | $48,000 | -44.2% | 93,948 | -36.8% | 0.00% | – |
| Q1 2017 | $86,000 | +36.5% | 148,672 | +48.5% | 0.00% | – |
| Q4 2016 | $63,000 | -71.7% | 100,101 | -58.9% | 0.00% | – |
| Q3 2016 | $223,000 | +87.4% | 243,436 | +8.7% | 0.00% | – |
| Q2 2016 | $119,000 | +8.2% | 223,957 | +90.7% | 0.00% | – |
| Q1 2016 | $110,000 | -99.3% | 117,461 | -99.0% | 0.00% | -100.0% |
| Q4 2015 | $16,426,000 | -41.7% | 12,350,837 | +0.0% | 0.01% | -33.3% |
| Q3 2015 | $28,153,000 | +41.5% | 12,347,732 | +0.3% | 0.01% | +50.0% |
| Q2 2015 | $19,891,000 | +1.9% | 12,315,931 | +0.3% | 0.01% | 0.0% |
| Q1 2015 | $19,518,000 | -17.9% | 12,275,376 | -2.4% | 0.01% | -20.0% |
| Q4 2014 | $23,764,000 | +44.0% | 12,573,774 | +0.6% | 0.01% | +66.7% |
| Q3 2014 | $16,500,000 | -12.0% | 12,499,905 | -1.4% | 0.01% | -25.0% |
| Q2 2014 | $18,757,000 | -21.3% | 12,673,511 | -1.6% | 0.01% | -27.3% |
| Q1 2014 | $23,828,000 | +743.2% | 12,879,943 | +843.5% | 0.01% | +1000.0% |
| Q4 2013 | $2,826,000 | +90.7% | 1,365,077 | +144.0% | 0.00% | – |
| Q3 2013 | $1,482,000 | -27.1% | 559,351 | -26.6% | 0.00% | -100.0% |
| Q2 2013 | $2,034,000 | – | 761,546 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|